Stock Fundamentals

Company Information

Company Name
Certara Inc
Sector
Healthcare
Industry
Health Information Services
Exchange
NASDAQ
ISIN: US15687V1098
CIK: 0001827090
CUSIP: 15687V109
Currency: USD
Full Time Employees: 1,515
Phone: 415 237 8272
Fiscal Year End: December
IPO Date: Dec 11, 2020
Description:

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.

Address:

4 Radnor Corporate Center, Radnor, PA, United States, 19087

Directors & Officers

Name Title Year Born
Mr. Leif E. Pedersen President & Chief Commercial Officer 1965
Mr. John E. Gallagher III SVP, Principal Accounting Officer & Chief Financial Officer 1973
Dr. Robert P. Aspbury Ph.D. President of Certara Predictive Technologies 1972
Dr. Adrian K. McKemey Ph.D. President of Drug Development Solutions NA
Mr. Jon Resnick CEO & Director 1973
Dr. Christopher Bouton Ph.D. Chief Technology Officer & Chief AI Officer NA
Mr. Daniel D. Corcoran Senior VP, General Counsel & Secretary 1967
Mr. Ron DiSantis Senior Vice President of Corporate Development NA
Ms. Sheila Rocchio MBA Chief Marketing Officer NA
Ms. Rona S. Anhalt Chief Human Resources Officer 1965

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 09, 2025 Leif E Pedersen N/A Sale 51.22K $10.92 $559.37K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 14.31M Mar 31, 2026 9.33% $0.00 2.74%
Vanguard Group Inc 11.92M Dec 31, 2025 7.77% $0.00 -3.96%
Dimensional Fund Advisors, Inc. 8.56M Mar 31, 2026 5.58% $0.01 2.09%
Deerfield Management Co 7.81M Mar 31, 2026 5.09% $0.53 0.00%
Wasatch Advisors LP 5.27M Mar 31, 2026 3.44% $0.20 -69.39%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 4.59M Mar 31, 2026 3.00% $0.70 -16.28%
Citadel Advisors Llc 4.55M Mar 31, 2026 2.96% $0.00 42.48%
State Street Corp 3.94M Mar 31, 2026 2.57% $0.00 0.55%
UBS Group AG 3.42M Mar 31, 2026 2.23% $0.00 37.40%
Morgan Stanley - Brokerage Accounts 3.24M Mar 31, 2026 2.11% $0.00 -35.91%
Jefferies Financial Group Inc 3.03M Dec 31, 2025 1.98% $0.14 0.00%
Teacher Retirement System Of Texas 2.96M Mar 31, 2026 1.93% $0.07 -47.15%
Geneva Capital Management 2.74M Mar 31, 2026 1.79% $0.33 -49.30%
Mackenzie Investments 2.72M Mar 31, 2026 1.77% $0.02 1.85%
Fort Washington Investment Advisors Inc 2.68M Mar 31, 2026 1.75% $0.08 17.72%
Brown Brothers Harriman & Co 2.51M Mar 31, 2026 1.64% $0.08 -33.39%
Ameriprise Financial Inc 2.25M Mar 31, 2026 1.47% $0.00 42.03%
Geode Capital Management, LLC 2.11M Mar 31, 2026 1.38% $0.00 -2.40%
Bank of America Corp 2.04M Mar 31, 2026 1.33% $0.00 292.19%
Dixon Mitchell Investment Counsel Inc 1.54M Mar 31, 2026 1.00% $0.30 -0.54%

Shares Statistics

Shares Outstanding: 155.56M
Shares Float: 107.30M
% Insiders: 256.00%
% Institutions: 11,249.70%
Short % Float: 25.18%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 7.30M 4.76% ▲ 0.03% Apr 30, 2026
2 Vanguard Total Stock Mkt Idx Inv 3.81M 2.48% ▲ 0.00% Apr 30, 2026
3 Vanguard Small Cap Index 2.75M 1.80% ▼ 0.43% Apr 30, 2026
4 Fort Washington Small Company Equity 2.62M 1.71% ▲ 22.24% Mar 31, 2026
5 Canada Life US Small-Mid Cap Growth F 2.02M 1.32% ▲ 0.00% Mar 31, 2026
6 Touchstone Small Company A 2.02M 1.32% ▲ 15.57% Mar 31, 2026
7 DFA US Small Cap Value I 2.02M 1.32% ▲ 9.50% Mar 31, 2026
8 First Trust Health Care AlphaDEX® ETF 1.99M 1.30% ▲ 0.00% Apr 30, 2026
9 Vanguard Explorer Inv 1.41M 0.92% ▼ 20.26% Mar 31, 2026
10 Wasatch Small Cap Value 1.37M 0.89% ▼ 20.14% Mar 31, 2026

Valuation Metrics

Enterprise Value: $1.10B
Trailing P/E: 0.00
Forward P/E: 12.67

Financial Highlights

Market Cap: $874.27M
EBITDA: $94.03M
Book Value: $6.63
Earnings/Share: $-0.10
Profit Margin: -3.60%
Operating Margin: 3.80%
ROA (TTM): 0.75%
ROE (TTM): -1.44%
Revenue (TTM): $419.75M
Revenue/Share (TTM): $2.63
Earnings Growth (YOY): -14.10%
Revenue Growth (YOY): 0.90%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 2.05x 0.28x 0.32x 1.06x 3.49x
2024-12-31 2.13x 0.28x 0.33x -0.08x 4.16x
2023-12-31 2.62x 0.28x 0.33x -1.78x 12.40x
2022-12-31 3.32x 0.28x 0.31x 1.83x 3.35x
2021-12-31 2.98x 0.29x 0.31x 0.81x 5.12x
2020-12-31 4.60x 0.36x 0.35x -0.97x 16.74x
2019-12-31 1.39x 0.82x 0.53x 0.70x 6.64x
2018-12-31 1.05x 0.83x 0.53x -0.17x 12.66x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CERT.US!